CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- 8-K Event Executive or director change
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Other events
- 8-K Event Material agreement · Other events
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- S-1MEF Other S-1MEF
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1 Offering Registration Statement
- 4 Option exercise Chief Executive Officer acquired 159,681 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 38,323 shares (option exercise)
- DRS Other Draft Registration Statement
- 8-K Event Regulation FD disclosure · Other events
- 4 Open-market buy Chief Financial Officer bought 20,000 shares at $0.51 ($10,200)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement · New debt or obligation
- 4 Option exercise Chief Executive Officer acquired 159,681 shares (option exercise)
- 4/A Derivatives Options or other derivatives
Page 4 of 74 · 1,465 filings